✦ LIBER ✦

19 Tumor necrosis factor-alpha antagonists and cardiovascular disease in inflammatory bowel disease

✍ Scribed by Nyboe Andersen, N.; Rungoe, C.; Andersson, M.; Munkholm, P.; Pasternak, B.; Jess, T.

Book ID: 122965951
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60020-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P432 Tumor necrosis factor-α antagonists

P432 Tumor necrosis factor-α antagonists and malignancy in inflammatory bowel disease

✍ N. Nyboe Andersen; S. Basit; H. Svanström; B. Pasternak; S. Caspersen; P. Munkho 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Tumor necrosis factor family members and

Tumor necrosis factor family members and inflammatory bowel disease

✍ Jing Wang; Yang-Xin Fu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

Exam 1: Therapeutic Drug Monitoring of T

Exam 1: Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease

✍ Matsumoto, Kenjiro; Hosoya, Takuji; Tashima, Kimihito; Horie, Syunji 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Optimizing anti-tumor necrosis factor st

Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease

✍ William J. Sandborn 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 247 KB

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha

Management of Inflammatory Bowel Disease

Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies

✍ Magro, Fernando; Portela, Francisco 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 290 KB